MPM's portfolio

MPM's portfolio

Company Business Region Last MPM round (A) Date Raised MPM directors
Acorda Neurology U.S. ND 5/9/03 $55.3 Michael Steinmetz
Affymax Cancer; Hematology U.S. Series C 6/23/03 $40.0 Nicholas Galakatos
Amphora Chemistry; Genomics U.S. Series C 12/8/04 $20.0 Michael Steinmetz
Arriva Pulmonary; Inflammation; Infectious U.S. Series D 5/6/02 $28.0 Ansbert Gadicke, Edward Mascioli
ARYx Cardiovascular;

Read the full 641 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE